{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:10:49Z","timestamp":1780967449343,"version":"3.54.1"},"reference-count":29,"publisher":"VM Media SP. zo.o VM Group SK","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","oncology-and-radiotherapy.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.rpor.2020.03.020","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T18:35:09Z","timestamp":1588012509000},"page":"562-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Total skin electron beam therapy for primary cutaneous T-cell lymphomas: clinical characteristics and outcomes in a Mexican reference center"],"prefix":"10.5603","volume":"25","author":[{"given":"Ch","family":"Flores-Balc\u00e1zar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DM","family":"Ur\u00edas-Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Charli-Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"De Le\u00f3n-Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SI","family":"P\u00e9rez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ramos-Prudencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3595","reference":[{"issue":"21","key":"10.1016\/j.rpor.2020.03.020_bib0005","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: A population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.rpor.2020.03.020_bib0010","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.rpor.2020.03.020_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome - Update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.rpor.2020.03.020_bib0020","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.rpor.2020.03.020_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hon.2584","article-title":"Cutaneous lymphomas-An update 2019","volume":"37","author":"Kempf","year":"2019","journal-title":"Hematol Oncol"},{"issue":"5","key":"10.1016\/j.rpor.2020.03.020_bib0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000470845","article-title":"Renaissance of low-dose radiotherapy concepts for cutaneous lymphomas","volume":"40","author":"Dabaja","year":"2017","journal-title":"Oncol Res Treat"},{"issue":"10","key":"10.1016\/j.rpor.2020.03.020_bib0035","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.rpor.2020.03.020_bib0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1396-0296.2003.01647.x","article-title":"Mycosis fungoides: Radiation therapy","volume":"16","author":"Hoppe","year":"2003","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.rpor.2020.03.020_bib0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"Modern radiation therapy for primary cutaneous lymphomas: Field and dose guidelines from the international lymphoma radiation oncology group","volume":"92","author":"Specht","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.rpor.2020.03.020_bib0050","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00066-018-1263-9","article-title":"Dose optimization of total or partial skin electron irradiation by thermoluminescent dosimetry","volume":"194","author":"Sch\u00fcttrumpf","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.rpor.2020.03.020_bib0055","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.rpor.2020.03.020_bib0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaad.2007.12.021","article-title":"Stem cell transplantation in advanced cutaneous T-cell lymphoma","volume":"58","author":"Introcaso","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.rpor.2020.03.020_bib0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jdcr.2017.02.004","article-title":"Complete durable remission of a fulminant primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma after autologous and allogeneic hematopoietic stem cell transplantation","volume":"3","author":"Plachouri","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.rpor.2020.03.020_bib0070","first-page":"623","article-title":"High energy electrons for the treatment of extensive superficial malignant lesions","volume":"69","author":"Trump","year":"1953","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"9","key":"10.1016\/j.rpor.2020.03.020_bib0075","first-page":"1985","article-title":"Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the S\u00e9zary syndrome)","volume":"85","author":"Jones","year":"1999","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.rpor.2020.03.020_bib0080","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0360-3016(94)90103-1","article-title":"Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 Gy","volume":"28","author":"Jones","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.rpor.2020.03.020_bib0085","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0360-3016(97)00127-2","article-title":"Total skin electron beam therapy followed by adjuvant psoralen\/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)","volume":"38","author":"Quiros","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.rpor.2020.03.020_bib0090","first-page":"275","article-title":"Total skin electron beam therapy (TSEBT) in the management of mycosis fungoides: Single institution experience","volume":"15","author":"Shouman","year":"2003","journal-title":"J Egyptian Nat Cancer Inst"},{"issue":"4","key":"10.1016\/j.rpor.2020.03.020_bib0095","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ijrobp.2003.08.007","article-title":"Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation)","volume":"58","author":"Ysebaert","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.rpor.2020.03.020_bib0100","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archdermatol.2011.98","article-title":"The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides","volume":"147","author":"Navi","year":"2011","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.rpor.2020.03.020_bib0105","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1016\/j.ijrobp.2011.01.023","article-title":"Revisiting low-dose total skin electron beam therapy in mycosis fungoides","volume":"81","author":"Harrison","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.rpor.2020.03.020_bib0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2015.01.047","article-title":"Low-dose (10Gy) total skin electron bream therapy for cutaneous T-cell lymphoma: An open clinical study and pooled data analysis","volume":"92","author":"Kamstrup","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2020.03.020_bib0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaad.2014.10.014","article-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials","volume":"72","author":"Hoppe","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.rpor.2020.03.020_bib0120","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2015.08.041","article-title":"Total skin electron beam for primary cutaneous T-cell lymphoma","volume":"93","author":"Elsayad","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.rpor.2020.03.020_bib0125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000475634","article-title":"Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma","volume":"40","author":"Elsayad","year":"2017","journal-title":"Oncol Res Treat"},{"issue":"12","key":"10.1016\/j.rpor.2020.03.020_bib0130","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00066-017-1188-8","article-title":"Low-dose total skin electron beam therapy for cutaneous lymphoma: Minimal risk of acute toxicities","volume":"193","author":"Kroeger","year":"2017","journal-title":"Strahlenter Onkol"},{"issue":"2","key":"10.1016\/j.rpor.2020.03.020_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clml.2018.11.015","article-title":"Total skin electron beam therapy for mycosis fungoides revisited with adjuvant systemic therapy","volume":"19","author":"Rivers","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.rpor.2020.03.020_bib0140","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2340\/00015555-3124","article-title":"Low- vs. Middle-dose total skin electron beam therapy for mycosis fungoides: An efficiency-based retrospective survey of skin response","volume":"99","author":"Taverniers","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.rpor.2020.03.020_bib0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00066-019-01517-7","article-title":"Low-dose total skin Electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or sezary syndrome","volume":"196","author":"Elsayad","year":"2020","journal-title":"Strahlenther Onkol"}],"container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720300493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720300493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T14:15:55Z","timestamp":1613657755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136720300493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1507136720300493"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2020.03.020","relation":{},"ISSN":["1507-1367"],"issn-type":[{"value":"1507-1367","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total skin electron beam therapy for primary cutaneous T-cell lymphomas: clinical characteristics and outcomes in a Mexican reference center","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2020.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}